Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

AllenaPharmaceuticals Inc. (NASDAQ:ALNA) Stock Drops Sharply: Should You Panic?

AllenaPharmaceuticals Inc. (NASDAQ:ALNA) dropped 35% after announcing a registered direct offering of around 21.3 million shares of its common stock plus a warrant to buy around 10.7 million shares at a price per share of $1.311.

The offering is likely to close on July 16, and the company expects gross proceeds of $28 million. The warrants have a five-year expiry, and they are exercisable immediately at $1.25 per share. The company is planning to use direct offering’s net proceeds for general corporate purposes and working capital.

Allena is offering the foregoing securities according to the “shelf” Registration Statement on Form S-3 (No. 333-2228656) previously filed with the SEC on December 3, 2018, which the SEC declared effective on December 26, 2018. Early in the week, the company offered updates on reloxaliase (ALLNN-177) and ALLN-346 clinical programs. The company preponed reloxaliase interim analysis from Q2/Q3 2022 to Q1 2022. Allena is o track to offer preliminary Phase 2a ALLN0346 results at the end of the year. So, in the coming month, ALNA is a stock to watch.

Market Reaction:

On Wednesday, ALNA stock slumped over 25% at $0.9030 with more than 44.45 million shares, compared to its average volume of 614k shares. The stock had moved within a range of $0.8780 – 1.0400 after opening the trade at $0.99. Over the past 52-week, the stock has been trading within a range of $0.8780 – 2.7800.

Published by Pete Matthews

Pete attended the University of Colorado and still calls the centennial state home. He chases trout in the summer and snowboards in the winter. He is fascinated with the markets and has a strong interest in nanocap stocks and crypto currency.

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.